Haemonetics (HAE) Misses Q4 EPS by 21c, Revenues Beat; Offers FY22 EPS Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| HAEMONETICS CORPORATION (NYSE: HAE) | Delayed: 120.28 +0.14 (0.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $120.14 | 52 Week High | $39.41 | |||
| Open | $119.07 | 52 Week Low | $25.98 | |||
| Day High | $121.44 | P/E | 169.41 | |||
| Day Low | $119.00 | EPS | $0.71 | |||
| Volume | 834,603 | |||||
